1. Home
  2. MAA vs SLRX Comparison

MAA vs SLRX Comparison

Compare MAA & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid-America Apartment Communities Inc.

MAA

Mid-America Apartment Communities Inc.

HOLD

Current Price

$132.11

Market Cap

15.3B

Sector

Real Estate

ML Signal

HOLD

Logo Salarius Pharmaceuticals Inc.

SLRX

Salarius Pharmaceuticals Inc.

HOLD

Current Price

$0.79

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAA
SLRX
Founded
1977
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3B
3.6M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MAA
SLRX
Price
$132.11
$0.79
Analyst Decision
Buy
Analyst Count
20
0
Target Price
$155.30
N/A
AVG Volume (30 Days)
907.6K
664.7K
Earning Date
02-04-2026
11-14-2025
Dividend Yield
4.59%
N/A
EPS Growth
6.34
N/A
EPS
4.71
N/A
Revenue
$2,203,402,000.00
N/A
Revenue This Year
$1.82
N/A
Revenue Next Year
$2.24
N/A
P/E Ratio
$28.03
N/A
Revenue Growth
0.92
N/A
52 Week Low
$125.75
$0.71
52 Week High
$173.38
$108.00

Technical Indicators

Market Signals
Indicator
MAA
SLRX
Relative Strength Index (RSI) 48.38 26.49
Support Level $131.32 $0.81
Resistance Level $133.72 $0.89
Average True Range (ATR) 2.02 0.07
MACD -0.14 0.10
Stochastic Oscillator 31.30 8.25

Price Performance

Historical Comparison
MAA
SLRX

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Share on Social Networks: